CompletedPHASE2, PHASE3NCT03742518

A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

Studying Alopecia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Biosplice Therapeutics, Inc.
Principal Investigator
Yusuf Yazici, M.D., MD
Biosplice Therapeutics, Inc.
Intervention
Topical SM04554 solution(drug)
Enrollment
675 target
Eligibility
18-45 years · MALE
Timeline
2018 – 2020

Study locations (11)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03742518 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia →

← Back to all trials